Form 8-K - Current report:
SEC Accession No. 0001104659-23-105027
Filing Date
2023-09-29
Accepted
2023-09-29 07:38:34
Documents
40
Period of Report
2023-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327162d2_8k.htm   iXBRL 8-K 33911
2 EXHIBIT 99.1 tm2327162d2_ex99-1.htm EX-99.1 29224
3 EXHIBIT 99.2 tm2327162d2_ex99-2.htm EX-99.2 35243
8 GRAPHIC tm2327162d2_ex99-1img001.jpg GRAPHIC 5831
9 GRAPHIC tm23271621d2_ex99-2img001.jpg GRAPHIC 74282
10 GRAPHIC tm23271621d2_ex99-2img002.jpg GRAPHIC 68650
11 GRAPHIC tm23271621d2_ex99-2img003.jpg GRAPHIC 359741
12 GRAPHIC tm23271621d2_ex99-2img004.jpg GRAPHIC 63397
13 GRAPHIC tm23271621d2_ex99-2img005.jpg GRAPHIC 212020
14 GRAPHIC tm23271621d2_ex99-2img006.jpg GRAPHIC 167708
15 GRAPHIC tm23271621d2_ex99-2img007.jpg GRAPHIC 45991
16 GRAPHIC tm23271621d2_ex99-2img008.jpg GRAPHIC 125410
17 GRAPHIC tm23271621d2_ex99-2img009.jpg GRAPHIC 122862
18 GRAPHIC tm23271621d2_ex99-2img010.jpg GRAPHIC 165533
19 GRAPHIC tm23271621d2_ex99-2img011.jpg GRAPHIC 173939
20 GRAPHIC tm23271621d2_ex99-2img012.jpg GRAPHIC 102647
21 GRAPHIC tm23271621d2_ex99-2img013.jpg GRAPHIC 117171
22 GRAPHIC tm23271621d2_ex99-2img014.jpg GRAPHIC 141039
23 GRAPHIC tm23271621d2_ex99-2img015.jpg GRAPHIC 182901
24 GRAPHIC tm23271621d2_ex99-2img016.jpg GRAPHIC 178711
25 GRAPHIC tm23271621d2_ex99-2img017.jpg GRAPHIC 142349
26 GRAPHIC tm23271621d2_ex99-2img018.jpg GRAPHIC 178121
27 GRAPHIC tm23271621d2_ex99-2img019.jpg GRAPHIC 45751
28 GRAPHIC tm23271621d2_ex99-2img020.jpg GRAPHIC 192894
29 GRAPHIC tm23271621d2_ex99-2img021.jpg GRAPHIC 193964
30 GRAPHIC tm23271621d2_ex99-2img022.jpg GRAPHIC 31821
31 GRAPHIC tm23271621d2_ex99-2img023.jpg GRAPHIC 209036
32 GRAPHIC tm23271621d2_ex99-2img024.jpg GRAPHIC 92846
  Complete submission text file 0001104659-23-105027.txt   5018707

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20230929.xsd EX-101.SCH 3893
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20230929_def.xml EX-101.DEF 27150
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20230929_lab.xml EX-101.LAB 37075
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20230929_pre.xml EX-101.PRE 25774
34 EXTRACTED XBRL INSTANCE DOCUMENT tm2327162d2_8k_htm.xml XML 5715
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 231291848
SIC: 2834 Pharmaceutical Preparations